Cryptococcus neoformans var. gattii in the koala (Phascolarctos cinereus): Serological evidence for subclinical cryptococcosis

Medical Mycology

Volumn 40, Issue 3, 2002, Pages 273-282

  Krockenberger, M B ^a   Canfield, P J ^a   Barnes, J ^b   Vogelnest, L ^b   Connolly, J ^a   Ley, C ^c   Malik, R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Taronga Zoo   (Australia)

^c Pacific Vetcare   (Australia)

Author keywords

Cryptococcus neoformans var. gattii; Koala; Subclinical

Indexed keywords

BACTERIAL ANTIGEN; FUNGUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BEAR; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DATA ANALYSIS; DISEASE COURSE; EUCALYPTUS; FEMALE; FUNGAL DETECTION; IMMUNE RESPONSE; INFECTIOUS PNEUMONIA; KOALA; LUNG INJURY; MALE; MENINGOENCEPHALITIS; MYCOSIS; NONHUMAN; NOSE CAVITY; ORGANISM COLONY; OUTCOMES RESEARCH; PARANASAL SINUS DISEASE; RESPIRATORY TRACT INJURY; SEROLOGY; SEROTYPE; SPECIES; AGGLUTINATION TEST; ANIMAL; ANIMAL DISEASE; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MARSUPIAL; PNEUMONIA;

ANIMALIA; BACTERIA (MICROORGANISMS); CRYPTOCOCCUS BACILLISPORUS; EUCALYPTUS; FILOBASIDIELLA NEOFORMANS; PHASCOLARCTIDAE; PHASCOLARCTOS CINEREUS;

AGGLUTINATION TESTS; ANIMALS; ANTIGENS, FUNGAL; AUTOPSY; COHORT STUDIES; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE PROGRESSION; FEMALE; MALE; MARSUPIALIA; MENINGOENCEPHALITIS; PNEUMONIA;

EID: 0036302092     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/mmy.40.3.273.282     Document Type: Article

References (55)

1. Veterinary aspects of cryptococcosis
2. Epidemiologic differences between the two varieties of Cryptococcus neoformans
3. High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions
4. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis
5. Cryptococcosis in the era of AIDS: 100 years after the discovery of Cryptococcus neoformans
6. Ecology of Cryptococcus neoformans and prevalence of its two varieties in AIDS and non-AIDS associated cryptococcosis
7. Polysaccharide antigens of the capsule of Cryptococcus neoformans
8. Cryptococcus neoformans var. grubii: Separate varietal status for Cryptococcus neoformans serotype A isolates
9. Diagnosis of cryptococcosis and monitoring of chemotherapy
10. Natural habitat of Cryptococcus neoformans var. gattii
11. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans
12. Environmental isolation of Cryptococcus neoformans var. gattii from California
13. Environmental isolation of Cryptococcus neoformans var. gattii from Eucalyptus tereticornis
14. The ecology of Cryptococcus neoformans
15. Distribution of Cryptococcus neoformans var. gattii among the species of Eucalyptus
16. Additional eucalypt hosts for Cryptococcus neoformans var. gattii
17. Presence of alpha and a mating types in environmental and clinical collections of Cryptococcus neoformans var. gattii strains from Australia
18. Tree preferences of the koala
19. Asymptomatic carriage of Cryptococcus neoformans in the nasal cavity of dogs and cats
20. Asymptomatic carriage of Cryptococcus neoformans in the nasal cavity of the koala (Phascolarctos cinereus)
21. Serum antibody response to Cryptococcus neoformans in cats, dogs and koalas with and without active infection
22. Cryptococcosis in the koala (Phascolarctos cinereus)
23. Morbidity and mortality in the koala (Phascolarctos cinereus)
24. The prevalence of cryptococcosis in the koala (Phascolarctus cinereus)
25. Cryptococcosis in koalas in Western Australia
26. A disease outbreak involving pneumonia in captive koalas
27. Meningoencephalitis in a koala (Phascolarctus cinereus) due to Cryptococcus neoformans var. gattii infection
28. Nasopharyngeal cryptococcosis
29. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat
30. Serum cryptococcal antigen in patients with AIDS
31. A latex cryptococcal antigen agglutination test for diagnosis and monitoring of therapy for cryptococcosis
32. Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination
33. Comparison of three commercial cryptococcal latex kits for detection of cryptococcal antigen
34. Specificity of the latex test for cryptococcal antigen: A rapid, simple method for eliminating interference factors
35. Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen
36. Comparison of commercial kits for detection of cryptococcal antigen
37. The primary pulmonary lymph node complex of cryptococcosis
38. Tissue changes and tissue diagnosis of cryptococcosis: A study of 26 cases
39. Primary complex of Cryptococcus and pulmonary lymph nodes
40. Cryptococcal antigenaemia in HIV-infected patients
41. Pulmonary cryptococcosis in patients without HIV infection
42. Pulmonary cryptococcosis in the immunocompetent host: Therapy with oral fluconazole: A report of four cases and a review of the literature
43. Epidemiological evidence for dormant Cryptococcus neoformans infection
44. Cryptococcus neoformans in the koala (Phascolarctos cinereus): Colonisation by C. n. var. gattii and investigation of environmental sources
45. An immunohistochemical method that differentiates Cryptococcus neoformans varieties and serotypes in formalin-fixed paraffin-embedded tissues
46. Mating types and serotypes of Cryptococcus neoformans isolated in Japan
47. Serotypes of Australian environmental and clinical isolates of Cryptococcus neoformans
48. Diagnosis, identification and epidemiology of Cryptococcus neoformans infection
49. The value of cryptococcal serum antigen screening among HIV-positive/AIDS patients in Kinshasa, Zaire
50. Low yield of screening for cryptococcal antigen by latex agglutination assay on serum and cerebrospinal fluid from Danish patients with AIDS or ARC
51. Detection of Cryptococcus neoformans capsular polysaccharide antigen in asymptomatic HIV-infected patients
52. Persistence of cryptococcal antigenemia in an infected dog and uninfected rabbits
53. Host-pathogen interactions: Basic concepts of microbial commensalism, colonization, infection, and disease
54. Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting